FRANKFURT (Reuters) - Bayer investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker. "Bayer needs a new strategic positioning, which
Salesforce Inc on Friday named three new board directors, including the chief of hedge fund ValueAct Capital, amid pressure from activist investors for better cost control and a management shakeup at
Bayer is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to
Bayer is facing
demands from activist investor Bluebell Capital Partners to
break up, a person familiar with the matter told Reuters,
pushing shares in the diversified health and agriculture group
to. | January 11, 2023
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - Bayer predicted on Tuesday its experimental drug against dangerous blood clots could make mo.